High Content & Phenotypic Screening 2017

Home
|
Posters
|

Agenda
- Keynote Speakers
- Agenda Day 1
- Agenda Day 2
|
Exhibition
|
Venue
|
Media
|

Keynote Speakers

Lorenz Mayr
Vice President, AstraZeneca Ltd

Jeffrey Morgan
Professor of Medical Science and Engineering, Brown University

Leo Price
CEO, Ocello B.V

Overview

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Information and local registration facilities for this conference is also available in:

Japanese |

Korean | Chinese(Simplified) |

Chinese(Traditional)

Agenda Topics

High Throughput Screening
Image Analysis and Data Management
Phenotypic and High Content Screening of 3D Models
Phenotypic Drug Discovery
Phenotypic Screening for New Targets

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Distinguished Faculty

Anthony Davies, Director of Translational Cell Imaging, The Queensland University of Technology
Davide Danovi, Director, Cell Phenotyping Platform, Kings College London
Chris Bakal, Dynamical Cell Systems Team Leader, Institute of Cancer Research
Andrew Barlow, Field Application Specialist, Thermo Fisher Scientific
Kamyar Hadian, Group Leader, Helmholtz Zentrum München
Matthias Nees, Group Leader, University of Turku
Christopher Schofield, Group Leader/Investigator, GlaxoSmithKline
Wolfram-Hubertus Zimmermann, Professor, University Medical Center Goettingen
Bob Van de Water, Professor, Leiden University
Armin Wolf, Professor/Director, Novartis Institutes for BioMedical Research
Stephen Brown, RNAi Facility Screening Manager, Sheffield University
Anton Simeonov, Scientific Director, National Institutes of Health
Alexander Baumann, Senior Director, DiscoveRx Corporation
Michael Jackson, Senior Vice President, Drug Discovery and Development, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking